This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: National Cancer Center. Active years: 2013-2018.
Location History:
- Goyang-si, KR (2013 - 2014)
- Gyeonggi-do, KR (2015 - 2018)
Company Filing History:
Years Active: 2013-2018
Title: In-Hoo Kim: Innovator in Cancer Therapeutics
Introduction
In-Hoo Kim is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of cancer therapeutics, holding a total of 5 patents. His innovative work focuses on developing advanced treatments that enhance safety and efficacy in cancer care.
Latest Patents
One of his latest patents is titled "Recombinant adenovirus with increased safety and anticancer activities, and use thereof." This invention relates to a recombinant adenovirus designed to improve in-vivo safety, tissue specificity, and anticancer effects. The recombinant adenovirus includes a liver tissue-specific promoter, a trans-splicing ribozyme, and a therapeutic or reporter gene, demonstrating remarkable safety and specificity for target tissues.
Another notable patent is the "Photosensitizer-metal nanoparticle complex and composition containing the complex for photodynamic therapy or diagnosis." This complex combines a photosensitizer with a metal nanoparticle, linked by a polypeptide substrate that can be degraded by a protease. This innovative approach allows for selective activation of the photosensitizer in tumor tissues, enhancing the effectiveness of tumor destruction and improving diagnostic accuracy.
Career Highlights
In-Hoo Kim is currently affiliated with the National Cancer Center, where he continues to advance research in cancer treatment. His work has garnered attention for its potential to revolutionize therapeutic strategies in oncology.
Collaborations
He collaborates with esteemed colleagues such as Jin-Sook Jeong and Bo-Seung Jang, contributing to a dynamic research environment focused on innovative cancer solutions.
Conclusion
In-Hoo Kim's contributions to cancer therapeutics through his patents and research at the National Cancer Center highlight his role as a leading inventor in the field. His innovative approaches promise to enhance the safety and effectiveness of cancer treatments, making a significant impact on patient care.